Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes
NCT00738023Phase 4Completed
- Sponsor
- Emory University
- Start
- Mar 2004
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rosiglitazone in hypertension (HTN) (2 arms), sponsored by Emory University. Primary endpoint: Changes in Systolic Blood Pressure During Initial Intralipid Infusion at 48 hours. Started Mar 2004; status: completed.
02
Drugs
rosiglitazone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00738023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00738023.